Turnover: ()
Country: United Kingdom
Randox is a company specializing in innovative diagnostic technologies to improve health in areas such as heart disease, diabetes, Alzheimer's disease, cancer and stroke. It is based in Northern Ireland, but exports its products to over 145 countries worldwide. Randox is dedicated to the research and development of cutting-edge tests for common diseases.
News
Sudbury: technology company receives £3.8 million from Randox 22/07/2022
- Verv Technologies, a Sudbury-based company specializing in medical technologies, has secured $3.8 million from its main UK investor
- The funding comes from Randox Laboratories, a world-renowned leader in biotechnology and laboratory services.
- Dr. Peter Fitzgerald, founder and CEO of Randox, will join Verv's Board of Directors
- Verv plans to use the investment to accelerate commercial product development, expand the range of consumer tests, strengthen its team and complete regulatory processes over the next year.
Studies mentioning this company
The bioanalysis market - France
Other companies mentioned:
- Eurofins
- Carso groupe
- Mérieux NutriSciences
- SGS
- Intertek
- Bureau Veritas BV
- Phytocontrol
- Qualtech (IFBM Groupe)
- Valbiotis
- Abbott Groupe
- Agilent Technologies
- Beckman Coulter
- Bio-Rad Laboratories
- Genomic Vision
- LFB Groupe
- Novacyt
- Qiagen
- Randox Laboratories
- Roche Diagnostics France (Roche Group)
- Thermo Fisher Diagnostics